Collectively, these findings highlight the potential of TGR5 agonism to address multiple pathophysiological features of obesity, including hyperphagia, insulin resistance, lipid accumulation, and reduced energy expenditure. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.